Literature DB >> 23924285

Acute kidney injury in peripheral arterial surgery patients: a cohort study.

Schiller Adalbert1, Mihaescu Adelina, Timar Romulus, Bob Flaviu Raul, Timar Bogdan, Boieru Raluca, Ionac Mihai.   

Abstract

PURPOSE: The aim of the study was to evaluate the prevalence of acute kidney injury (AKI) in a cohort of surgically treated patients with peripheral artery disease (PAD) and its association with the short-term and long-term outcome.
MATERIALS AND METHODS: We conducted a retrospective cohort study on all the consecutive PAD inpatients in 2008. Data on the patients' demographic characteristics, medical history, treatment, outcome and laboratory tests measurements were retrieved from the medical records.
RESULTS: We analyzed 166 patients (71.6% males, mean age 63.2 years ± SD 10.7 years) and found an AKI prevalence of 12.7%. The AKI patients' group had more chronic kidney disease (CKD) (23.8% vs. 6.2%, p = 0.005), diabetes mellitus (DM) (61.9% vs. 33.1%, p = 0.011) and a higher length of hospital stay (19.48 vs. 15.42 days, p = 0.047). At one year, the mortality was 33.3% in the AKI group compared to 1.3% in non-AKI group, with a strong association between AKI and death (OR = 35.7; 95%CI = 6.7 to 189) and AKI and major cardiovascular events (OR = 29.1; 95% CI = 6.8 to 123.4). There was no significant difference in terms of age, cardiovascular disease and medication between the two groups.
CONCLUSIONS: AKI was associated with a poorer one-year outcome after the surgery of PAD patients. In our study, the presence of previous chronic kidney disease and type 2 diabetes increased the incidence of acute kidney injury after surgery.

Entities:  

Mesh:

Year:  2013        PMID: 23924285     DOI: 10.3109/0886022X.2013.823830

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  8 in total

1.  Mortality and Cost of Acute and Chronic Kidney Disease after Vascular Surgery.

Authors:  Matthew Huber; Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Philip A Efron; Robert Feezor; Charles Hobson; Azra Bihorac
Journal:  Ann Vasc Surg       Date:  2015-07-14       Impact factor: 1.466

2.  Cardiovascular-Specific Mortality and Kidney Disease in Patients Undergoing Vascular Surgery.

Authors:  Matthew Huber; Tezcan Ozrazgat-Baslanti; Paul Thottakkara; Salvatore Scali; Azra Bihorac; Charles Hobson
Journal:  JAMA Surg       Date:  2016-05-01       Impact factor: 14.766

Review 3.  Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient.

Authors:  Charles Hobson; Nicholas Lysak; Matthew Huber; Salvatore Scali; Azra Bihorac
Journal:  J Vasc Surg       Date:  2018-06-28       Impact factor: 4.268

4.  Acute kidney injury, long-term renal function and mortality in patients undergoing major abdominal surgery: a cohort analysis.

Authors:  Joana Gameiro; Joana Briosa Neves; Natacha Rodrigues; Catarina Bekerman; Maria João Melo; Marta Pereira; Catarina Teixeira; Inês Mendes; Sofia Jorge; Rosário Rosa; José António Lopes
Journal:  Clin Kidney J       Date:  2016-01-18

5.  Post-operative acute kidney injury in non-suprainguinal vascular surgery patients with a pre-operative history of hypertension.

Authors:  Yoshan Moodley; Bruce M Biccard
Journal:  EXCLI J       Date:  2015-03-02       Impact factor: 4.068

Review 6.  Acute kidney injury in major abdominal surgery: incidence, risk factors, pathogenesis and outcomes.

Authors:  Joana Gameiro; José Agapito Fonseca; Marta Neves; Sofia Jorge; José António Lopes
Journal:  Ann Intensive Care       Date:  2018-02-09       Impact factor: 6.925

Review 7.  Acute Renal Failure/Acute Kidney Injury (AKI) Associated with Endovascular Procedures.

Authors:  Zbigniew Krasinski; Beata Krasińska; Marta Olszewska; Krzysztof Pawlaczyk
Journal:  Diagnostics (Basel)       Date:  2020-05-02

8.  Remote Ischaemic Preconditioning Reduces Kidney Injury Biomarkers in Patients Undergoing Open Surgical Lower Limb Revascularisation: A Randomised Trial.

Authors:  Teele Kasepalu; Karl Kuusik; Urmas Lepner; Joel Starkopf; Mihkel Zilmer; Jaan Eha; Mare Vähi; Jaak Kals
Journal:  Oxid Med Cell Longev       Date:  2020-01-23       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.